ImmunityBio, Inc. shared on X:
“We’re excited to join the World Bladder Cancer Patient Forum 2026 in Hong Kong, bringing together voices from across the globe to advance bladder cancer care and advocacy.
Today, ImmunityBio’s Anjali Malhotra joined a panel on patient-centric clinical trial design, contributing to an important conversation about putting patients at the center of research.”
You can also read:
Renal Function and Oncological Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer
